NCT04511819 - Losmapimod Safety and Efficacy in COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

COVID-19

Interventions

DRUG

Losmapimod oral tablet

Losmapimod will be administered with food when possible.

DRUG

Placebo oral tablet

Placebo will be administered with food when possible.

Trial Locations (16)

33136

University of Miami, Miami

33606

University of South Florida, Tampa

44280

Hospital Civil Fray Antonio Alcalde, Guadalajara

44340

Nuevo Hospital Civil de Guadalajara, Guadalajara

77030

Memorial Hermann Hospital South West, Houston

University of Texas Health Science Center at Houston, Houston

77091

United Medical Memorial Hospital, Houston

80230

Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C., Culiacán

92697

University of California Irvine - Irvine Medical Center, Irvine

662284

JM Research Cuernavaca, Cuernavaca

29043260

Hospital Universitario Cassiano Antonio de Moraes-HUCAM/Hospital das Clinicas, Vitória

30150221

Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte

02215

Beth Israel Deaconess Medical Center, Boston

90035-075

Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre

04550-000

Hospital Santa Paula, São Paulo

04001

Hospital Nacional Carlos Alberto Seguín Escobedo - EsSalud Arequipa, Arequipa